Stockscreener 앱 받기
17.14
12.32%
1.88
Eton Pharmaceuticals Inc 주식(ETON)의 최신 뉴스
Eton Pharmaceuticals (NASDAQ:ETON) Downgraded to "Hold" Rating by Wall Street Zen - MarketBeat
Eton targets $80M revenue run-rate in Q3 2025 as product launches accelerate - MSN
Tools to monitor Eton Pharmaceuticals Inc. recovery probabilityWeekly Breakout Forecast with Entry Zones - Newser
Is Eton Pharmaceuticals Inc. stock reversal real or fakeTrade Safety Matrix for Conservative Traders - Newser
Eton (ETON) Q2 Revenue Jumps 108% - AOL.com
Quantitative breakdown of Eton Pharmaceuticals Inc. recent moveFree Stock Selection With High Accuracy - Newser
What does recent volatility data suggest for Eton Pharmaceuticals Inc.Free Secure Capital Picks With Upside Potential - Newser
Wall Street Zen Downgrades Eton Pharmaceuticals (NASDAQ:ETON) to Hold - Defense World
Published on: 2025-08-08 22:55:40 - Newser
What makes Eton Pharmaceuticals Inc. stock price move sharplyFree Capital Growth With Controlled Risk Picks - Newser
Eton Pharmaceuticals 2025 Q2 Earnings Narrowed Losses and Strong Revenue Growth - AInvest
What institutional flow reveals about Eton Pharmaceuticals Inc.Swing Candidate List with Trade Cues - Newser
Earnings call transcript: Eton Pharmaceuticals Q2 2025 reports strong growth By Investing.com - Investing.com Canada
Earnings call transcript: Eton Pharmaceuticals Q2 2025 reports strong growth - Investing.com
Eton Pharmaceuticals Soars 17.23% on 108% Sales Growth - AInvest
Eton Pharmaceuticals: Growth At A Reasonable Price, Or Maybe Even Better With Options - Seeking Alpha
Eton Pharmaceuticals Inc (ETON) Q2 2025 Earnings Call Highlights: Record Revenue Growth and ... By GuruFocus - Investing.com Canada
Eton Pharmaceuticals Reports Robust Q2 2025 Growth - TipRanks
Real time pattern detection on Eton Pharmaceuticals Inc. stockBuy/Sell Zone Confirmation Technical Analysis - Newser
Why Eton Pharmaceuticals Inc. is moving todayYield Curve Outlook and Long-Term Implication Summary - Newser
Eton Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Eton Pharmaceuticals reports Q2 non-GAAP EPS 3c, consensus 2c - TipRanks
Eton Pharmaceuticals earnings beat by $0.02, revenue topped estimates - Investing.com Canada
Eton Pharmaceuticals Reports Second Quarter 2025 Financial Results - GlobeNewswire
Signal strength of Eton Pharmaceuticals Inc. stock in tech scannersLow Risk High Confidence Watchlist Builder - Newser
Smart tools for monitoring Eton Pharmaceuticals Inc.’s price actionAI-Powered Stock Trend Movement Analysis - Newser
Quant Tools Rank Eton Pharmaceuticals Inc. as High Risk High RewardVerified Signal From Chart Patterns Detected - beatles.ru
How does Eton Pharmaceuticals Inc. compare to its industry peersMarket-leading profit generation - Jammu Links News
How many analysts rate Eton Pharmaceuticals Inc. as a “Buy”Get daily expert analysis for smarter investing - Jammu Links News
What is the risk reward ratio of investing in Eton Pharmaceuticals Inc. stockFree Stock Market Trend Analysis - Jammu Links News
How volatile is Eton Pharmaceuticals Inc. stock compared to the marketBoost your wealth with consistent growth stocks - Jammu Links News
Is Eton Pharmaceuticals Inc. a good long term investmentFree Stock Market Query - Jammu Links News
Is Eton Pharmaceuticals Inc. stock overvalued or undervaluedInvest smarter with actionable trading signals - Jammu Links News
Why is Eton Pharmaceuticals Inc. stock attracting strong analyst attentionAchieve consistent profits with smart trading - Jammu Links News
What catalysts could drive Eton Pharmaceuticals Inc. stock higher in 2025Track stocks with high upside potential easily - Jammu Links News
What are the technical indicators suggesting about Eton Pharmaceuticals Inc.Get exclusive market analysis for investors - Jammu Links News
What is the dividend policy of Eton Pharmaceuticals Inc. stockUnlock daily trading alerts for profits - Jammu Links News
Eton Pharmaceuticals Inc. Stock Analysis and ForecastBreakout stock performance - Jammu Links News
Eton Pharmaceuticals, Inc. (ETON) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance
Published on: 2025-07-30 01:43:42 - metal.it
Short Term Charts Align With Long Term Uptrend in Eton Pharmaceuticals Inc.Conservative Long Term Growth Plans Under Review - metal.it
RSI and MACD Indicate Shift in Eton Pharmaceuticals Inc. SentimentHigh Growth Low Risk Stock Selection Gets Analyst Nod - metal.it
How to interpret RSI for Eton Pharmaceuticals Inc. stockFree Step-by-Step Trade Signal Implementation - Newser
Eton Pharmaceuticals to Report Second Quarter 2025 Financial Results on Thursday, August 7, 2025 - GlobeNewswire
Eton Pharmaceuticals, Rare Disease Leader, Announces Q2 2025 Earnings Call Details for August 7 - Stock Titan
How Eton Pharmaceuticals Inc. stock reacts to Fed policy changesAlpha Stock Picks with Chart Confirmation - Newser
Is it the right time to buy Eton Pharmaceuticals Inc. stockCapitalize on market momentum for profits - jammulinksnews.com
0.43%
0.47%
자본화:
|
볼륨(24시간):